455 related articles for article (PubMed ID: 5796027)
1. [Present state of heparin therapy].
Blatrix C; Soulier JP; Vacheron A; Cornu P
Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
[No Abstract] [Full Text] [Related]
2. Blood coagulation studies and extracorporeal circulation in man.
Thurnherr N
Thromb Diath Haemorrh; 1967 Dec; 18(3-4):634-46. PubMed ID: 5590250
[No Abstract] [Full Text] [Related]
3. Heparin rebound. Studies in patients and volunteers.
Ellison N; Beatty CP; Blake DR; Wurzel HA; MacVaugh H
J Thorac Cardiovasc Surg; 1974 May; 67(5):723-9. PubMed ID: 4823307
[No Abstract] [Full Text] [Related]
4. Heparin therapy.
Raich PC; Hahn MF; Korst DR
Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
[No Abstract] [Full Text] [Related]
5. Control of heparin therapy.
Wessler S; Gitel S
Prog Hemost Thromb; 1976; 3():311-29. PubMed ID: 781735
[No Abstract] [Full Text] [Related]
6. Development of heparin fractions: some overlooked considerations.
Fareed J
Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
[No Abstract] [Full Text] [Related]
7. Implications of anticoagulant therapy.
Ellison N; Jobes DR; Schwartz AJ
Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
[No Abstract] [Full Text] [Related]
8. Adverse reactions associated with heparin therapy for ischemic heart disease and thrombophlebitis.
Mishler JM
Am J Hosp Pharm; 1973 Dec; 30(12):1158-61. PubMed ID: 4763223
[No Abstract] [Full Text] [Related]
9. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.
Rhodes GR; Dixon RH; Silver D
Surg Gynecol Obstet; 1973 Mar; 136(3):409-16. PubMed ID: 4688805
[No Abstract] [Full Text] [Related]
10. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
[No Abstract] [Full Text] [Related]
11. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
Ray PK; Harper TA
J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
[No Abstract] [Full Text] [Related]
12. Control and complications of intermittent heparin therapy.
Norman CS; Provan JL
Surg Gynecol Obstet; 1977 Sep; 145(3):338-42. PubMed ID: 888052
[TBL] [Abstract][Full Text] [Related]
13. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
Deutschinoff A; Dimitrov D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
[No Abstract] [Full Text] [Related]
14. Guidelines for heparin therapy.
Genton E
Ann Intern Med; 1974 Jan; 80(1):77-82. PubMed ID: 4589514
[No Abstract] [Full Text] [Related]
15. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
[No Abstract] [Full Text] [Related]
16. [Heparin].
Aiach M; Fiessinger JN; Chousterman M
Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
[No Abstract] [Full Text] [Related]
17. [Hemorrhagic complications caused by heparin therapy].
Fedorova ZD; Chuslov AG; Chermoshniuk GA; Levchenko LV; Khanin AZ
Vestn Khir Im I I Grek; 1989 Dec; 144(12):82-5. PubMed ID: 2638797
[TBL] [Abstract][Full Text] [Related]
18. [Heparinization in dialysis: new clinico-therapeutic directions].
Camici M; Evangelisti L
Clin Ter; 1993 Jan; 142(1):23-7. PubMed ID: 8472506
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism.
Kakkar VV
Clin Haematol; 1981 Jun; 10(2):543-82. PubMed ID: 6172228
[No Abstract] [Full Text] [Related]
20. A critical evaluation of anticoagulant therapy.
Wright IS
Geriatrics; 1969 Mar; 24(3):96-100. PubMed ID: 4885555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
